EncapX® at the 14th Antibody Industrial Symposium
3 July 2026 · Montpellier
Biotech One was at the 14th Antibody Industrial Symposium (AIS 2026) in Montpellier.
The symposium is a meeting point for people working on antibodies, biologics, drug discovery and preclinical development.
EncapX®, the millifluidic encapsulation platform using supercritical CO₂, was presented there as a clean and scalable route for the formulation of sensitive molecules. In this context, clean means no toxic solvents.
Related news
Biotech One pitches EncapX® to France BioLead members
An exclusive member session on 6 November, on bridging R&D formulation and industrial bioproduction for liposome and LNP manufacturing.
5 November 2026
EncapX® presented at the AFSSI webinar
A liposome and LNP formulation platform using supercritical CO₂, to protect fragile molecules and bridge R&D and industrial production.
26 October 2026
EncapX® on stage at World Vaccine Congress Europe 2026
Exhibitor in the Start-up Zone (booth SU3). Talk by Dr Elissandro Klein on continuous scCO₂ processing for vaccine delivery.
21 October 2026 · RAI Amsterdam